Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q90174035 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241120235818.0 | ||
008 | 241120nneanz||abbn n and d | ||
035 | ‡a (WKP)Q90174035 | ||
024 | ‡a 0000-0003-2040-4961 ‡2 orcid | ||
035 | ‡a (OCoLC)Q90174035 | ||
100 | 0 | ‡a Jennifer R Brown ‡c researcher ‡9 en | |
375 | ‡a 2 ‡2 iso5218 | ||
400 | 0 | ‡a Jennifer R Brown ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's A prospective study of minimal residual disease in patients with diffuse large B-cell lymphoma using an Ig-NGS assay | ||
670 | ‡a Author's Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect | ||
670 | ‡a Author's DUO delivers for duvelisib | ||
670 | ‡a Author's Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia | ||
670 | ‡a Author's Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis | ||
670 | ‡a Author's MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL | ||
670 | ‡a Author's Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukemia treated with idelalisib | ||
909 | ‡a (orcid) 0000000320404961 ‡9 1 | ||
919 | ‡a myd88l265pmutationsidentifyaprognosticgeneexpressionsignatureandapathwayfortargetedinhibitionincll ‡A MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL ‡9 1 | ||
919 | ‡a riskfactorsforgrade34transaminaseelevationinpatientswithchroniclymphocyticleukemiatreatedwithidelalisib ‡A Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukemia treated with idelalisib ‡9 1 | ||
919 | ‡a incidenceofandriskfactorsformajorhaemorrhageinpatientstreatedwithibrutinibanintegratedanalysis ‡A Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis ‡9 1 | ||
919 | ‡a efficacyresultsofaphase2trialof1lineidelalisibplusofatumumabinchroniclymphocyticleukemia ‡A Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia ‡9 1 | ||
919 | ‡a duodeliversforduvelisib ‡A DUO delivers for duvelisib ‡9 1 | ||
919 | ‡a distinctevolutionarypathsinchroniclymphocyticleukemiaduringresistancetothegraftversusleukemiaeffect ‡A Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect ‡9 1 | ||
919 | ‡a prospectivestudyofminimalresidualdiseaseinpatientswithdiffuselargebcelllymphomausinganigngsassay ‡A A prospective study of minimal residual disease in patients with diffuse large B-cell lymphoma using an Ig-NGS assay ‡9 1 | ||
946 | ‡a a ‡9 1 | ||
996 | ‡2 LC|n 2023035420 | ||
996 | ‡2 SUDOC|201776804 | ||
996 | ‡2 NTA|086967584 | ||
996 | ‡2 SUDOC|263917940 | ||
996 | ‡2 NUKAT|n 2010132555 | ||
996 | ‡2 DNB|1174691417 | ||
996 | ‡2 SUDOC|251367800 | ||
996 | ‡2 CAOONL|ncf13693618 | ||
996 | ‡2 NKC|jo2014839069 | ||
996 | ‡2 DNB|171369564 | ||
996 | ‡2 JPG|500028267 | ||
996 | ‡2 LC|nr 94031574 | ||
996 | ‡2 B2Q|0000274291 | ||
996 | ‡2 DNB|1043544038 | ||
996 | ‡2 LC|n 83009859 | ||
996 | ‡2 ISNI|0000000446171227 | ||
996 | ‡2 RERO|A025437109 | ||
996 | ‡2 ISNI|0000000051641175 | ||
996 | ‡2 NUKAT|n 2017182343 | ||
996 | ‡2 BNF|12340883 | ||
996 | ‡2 NTA|072385944 | ||
996 | ‡2 DNB|134915658 | ||
996 | ‡2 J9U|987007281191205171 | ||
996 | ‡2 BIBSYS|98061006 | ||
996 | ‡2 LC|n 2014053884 | ||
996 | ‡2 PLWABN|9813703869005606 | ||
996 | ‡2 CAOONL|ncf10534031 | ||
996 | ‡2 SUDOC|032365136 | ||
996 | ‡2 LC|n 00039326 | ||
996 | ‡2 NTA|11030490X | ||
996 | ‡2 BIBSYS|10011243 | ||
996 | ‡2 LC|no2003086959 | ||
996 | ‡2 NSK|000326304 | ||
996 | ‡2 RERO|A012621998 | ||
996 | ‡2 BNF|14024343 | ||
996 | ‡2 BLBNB|001009360 | ||
996 | ‡2 N6I|vtls000031252 | ||
996 | ‡2 BNF|14024345 | ||
996 | ‡2 LC|n 2019042669 | ||
996 | ‡2 SIMACOB|23464035 | ||
996 | ‡2 LC|n 2019020294 | ||
996 | ‡2 LC|nb2013005806 | ||
996 | ‡2 SUDOC|255245289 | ||
996 | ‡2 LC|n 85244498 | ||
996 | ‡2 DNB|1029522863 | ||
996 | ‡2 SUDOC|151318018 | ||
996 | ‡2 DNB|171992024 | ||
996 | ‡2 LC|no2010091928 | ||
996 | ‡2 LC|no 98083068 | ||
996 | ‡2 BIBSYS|8007463 | ||
996 | ‡2 SUDOC|242737900 | ||
996 | ‡2 ISNI|0000000495494663 | ||
996 | ‡2 DNB|1152408364 | ||
996 | ‡2 ISNI|0000000433612732 | ||
996 | ‡2 BIBSYS|90181220 | ||
996 | ‡2 ISNI|0000000384971666 | ||
996 | ‡2 NKC|jo2013779499 | ||
996 | ‡2 LC|n 92105961 | ||
996 | ‡2 NKC|jo2016917241 | ||
996 | ‡2 ISNI|000000042563822X | ||
996 | ‡2 ISNI|0000000019894498 | ||
996 | ‡2 LC|no2011158769 | ||
996 | ‡2 BNF|18050758 | ||
996 | ‡2 NKC|ola2017960354 | ||
996 | ‡2 ISNI|0000000109067250 | ||
996 | ‡2 RERO|A026884896 | ||
996 | ‡2 ISNI|0000000368743735 | ||
996 | ‡2 CAOONL|ncf10103517 | ||
996 | ‡2 RERO|A013168260 | ||
996 | ‡2 NUKAT|n 2011045948 | ||
996 | ‡2 LC|nb 99082740 | ||
996 | ‡2 LC|no2001080580 | ||
996 | ‡2 NTA|391735993 | ||
996 | ‡2 DNB|1033788228 | ||
996 | ‡2 NKC|xx0228647 | ||
996 | ‡2 ISNI|0000000051729644 | ||
996 | ‡2 SUDOC|188917225 | ||
996 | ‡2 J9U|987007576117205171 | ||
996 | ‡2 N6I|vtls002070249 | ||
996 | ‡2 LC|nr 91006185 | ||
996 | ‡2 LC|nb2021001428 | ||
996 | ‡2 NKC|xx0004119 | ||
996 | ‡2 CAOONL|ncf11397458 | ||
996 | ‡2 J9U|987007371606605171 | ||
996 | ‡2 CAOONL|ncf11403668 | ||
996 | ‡2 PTBNP|257610 | ||
996 | ‡2 LC|n 2004063205 | ||
996 | ‡2 ISNI|0000000451357552 | ||
996 | ‡2 LC|nr 92021696 | ||
996 | ‡2 ISNI|0000000049751893 | ||
996 | ‡2 CAOONL|ncf10179506 | ||
996 | ‡2 SUDOC|071284729 | ||
996 | ‡2 BIBSYS|90659066 | ||
996 | ‡2 RERO|A003048224 | ||
996 | ‡2 RERO|A003048225 | ||
996 | ‡2 NTA|069610339 | ||
996 | ‡2 LC|n 2022938523 | ||
996 | ‡2 N6I|vtls002421331 | ||
996 | ‡2 CAOONL|ncf10807652 | ||
996 | ‡2 BIBSYS|90220540 | ||
996 | ‡2 J9U|987007371623005171 | ||
996 | ‡2 ISNI|0000000390512829 | ||
996 | ‡2 J9U|987007426998205171 | ||
996 | ‡2 NSK|000259281 | ||
996 | ‡2 RERO|A006372218 | ||
996 | ‡2 RERO|A006372219 | ||
996 | ‡2 ISNI|0000000021618927 | ||
996 | ‡2 BIBSYS|90096526 | ||
996 | ‡2 RERO|A006372216 | ||
996 | ‡2 LC|n 2008079573 | ||
996 | ‡2 CAOONL|ncf10380355 | ||
996 | ‡2 DNB|172005515 | ||
996 | ‡2 NTA|153676124 | ||
996 | ‡2 ISNI|0000000082391025 | ||
996 | ‡2 LC|no2005068756 | ||
996 | ‡2 BIBSYS|90068577 | ||
996 | ‡2 B2Q|0000011421 | ||
996 | ‡2 NII|DA10890298 | ||
996 | ‡2 DNB|14312854X | ||
996 | ‡2 NII|DA05153406 | ||
996 | ‡2 LC|no2021109466 | ||
996 | ‡2 LC|nb2021000738 | ||
996 | ‡2 ISNI|0000000112828399 | ||
996 | ‡2 LC|no2005020163 | ||
996 | ‡2 SUDOC|112174663 | ||
996 | ‡2 NTA|097313246 | ||
996 | ‡2 BIBSYS|90138480 | ||
996 | ‡2 PTBNP|1196483 | ||
996 | ‡2 DNB|1251512798 | ||
996 | ‡2 LC|no2005100997 | ||
996 | ‡2 BIBSYS|99022480 | ||
996 | ‡2 NUKAT|n 2006109309 | ||
996 | ‡2 LC|n 2010060537 | ||
996 | ‡2 NYNYRILM|39394 | ||
996 | ‡2 ISNI|0000000109358197 | ||
996 | ‡2 ISNI|0000000076642780 | ||
996 | ‡2 ISNI|0000000050443134 | ||
996 | ‡2 J9U|987010188922005171 | ||
996 | ‡2 NUKAT|n 2017159667 | ||
996 | ‡2 NTA|072856823 | ||
996 | ‡2 LC|no2024078049 | ||
996 | ‡2 DBC|87097990308564 | ||
996 | ‡2 RERO|A003048265 | ||
996 | ‡2 RERO|A003048266 | ||
996 | ‡2 RERO|A003048267 | ||
996 | ‡2 JPG|500068740 | ||
996 | ‡2 ISNI|000000004824104X | ||
996 | ‡2 RERO|A003048268 | ||
996 | ‡2 ISNI|000000047240790X | ||
996 | ‡2 ISNI|0000000025263000 | ||
996 | ‡2 NTA|344497615 | ||
996 | ‡2 ISNI|0000000114642408 | ||
996 | ‡2 BNF|12021702 | ||
996 | ‡2 NTA|433000325 | ||
996 | ‡2 LC|no2016142871 | ||
996 | ‡2 NTA|331239760 | ||
996 | ‡2 ISNI|0000000457896514 | ||
996 | ‡2 BIBSYS|90147677 | ||
996 | ‡2 J9U|987007400624405171 | ||
996 | ‡2 LC|n 80153184 | ||
996 | ‡2 LC|n 2015072487 | ||
996 | ‡2 BNC|981058616161106706 | ||
996 | ‡2 ISNI|0000000496486841 | ||
996 | ‡2 CAOONL|ncf10137406 | ||
996 | ‡2 CAOONL|ncf10374879 | ||
996 | ‡2 DNB|1212802314 | ||
996 | ‡2 LC|n 97103554 | ||
996 | ‡2 CAOONL|ncf11964157 | ||
996 | ‡2 LC|no 90015316 | ||
996 | ‡2 VLACC|000039187 | ||
996 | ‡2 ISNI|0000000507733087 | ||
996 | ‡2 LC|no2024044036 | ||
996 | ‡2 ISNI|0000000357602056 | ||
996 | ‡2 DNB|1156970679 | ||
996 | ‡2 NTA|167561820 | ||
996 | ‡2 DNB|1318496853 | ||
996 | ‡2 LC|no2021091320 | ||
996 | ‡2 BIBSYS|13046396 | ||
996 | ‡2 DNB|103760394X | ||
996 | ‡2 LC|n 2017065461 | ||
996 | ‡2 LC|n 2017065463 | ||
996 | ‡2 J9U|987007361118705171 | ||
996 | ‡2 BAV|495_388251 | ||
996 | ‡2 LC|n 2003016211 | ||
996 | ‡2 BNF|16189122 | ||
996 | ‡2 CAOONL|ncf10039400 | ||
996 | ‡2 CAOONL|ncf12094826 | ||
996 | ‡2 NUKAT|n 2014082338 | ||
996 | ‡2 SUDOC|05971574X | ||
996 | ‡2 LC|no2013057121 | ||
996 | ‡2 LC|n 2019022126 | ||
996 | ‡2 J9U|987007425325505171 | ||
996 | ‡2 BNF|16736780 | ||
996 | ‡2 DNB|1052879551 | ||
996 | ‡2 BIBSYS|10027522 | ||
996 | ‡2 LC|n 85339763 | ||
996 | ‡2 ISNI|000000044884750X | ||
996 | ‡2 PLWABN|9810644198905606 | ||
996 | ‡2 PTBNP|1003533 | ||
996 | ‡2 J9U|987012747986705171 | ||
996 | ‡2 DNB|1062526392 | ||
996 | ‡2 NUKAT|n 2021025444 | ||
996 | ‡2 CAOONL|ncf10617277 | ||
996 | ‡2 ISNI|0000000034224222 | ||
996 | ‡2 LC|n 2019060828 | ||
996 | ‡2 LC|n 2013057548 | ||
996 | ‡2 CAOONL|ncf10731954 | ||
996 | ‡2 SUDOC|233054588 | ||
996 | ‡2 ISNI|0000000024510495 | ||
996 | ‡2 CAOONL|ncf11546106 | ||
996 | ‡2 BIBSYS|90264731 | ||
996 | ‡2 LC|nb2020008542 | ||
996 | ‡2 BIBSYS|90114367 | ||
996 | ‡2 SUDOC|183927044 | ||
996 | ‡2 LC|n 2012032479 | ||
996 | ‡2 CAOONL|ncf10036893 | ||
996 | ‡2 DNB|117113990X | ||
996 | ‡2 PLWABN|9810642867005606 | ||
996 | ‡2 B2Q|0001644302 | ||
996 | ‡2 N6I|vtls000043780 | ||
996 | ‡2 UIY|000084780 | ||
996 | ‡2 J9U|987007351720505171 | ||
996 | ‡2 LC|n 2019040496 | ||
996 | ‡2 DNB|1201595622 | ||
996 | ‡2 LC|no2021068515 | ||
996 | ‡2 NTA|071027335 | ||
996 | ‡2 ISNI|0000000399440286 | ||
996 | ‡2 ISNI|0000000044757903 | ||
996 | ‡2 LC|no2002109403 | ||
996 | ‡2 LC|no2015163382 | ||
996 | ‡2 BNF|16200631 | ||
996 | ‡2 NTA|089188241 | ||
996 | ‡2 DNB|141890762 | ||
996 | ‡2 RERO|A027683211 | ||
996 | ‡2 N6I|vtls002658312 | ||
996 | ‡2 ISNI|0000000050292903 | ||
996 | ‡2 ISNI|0000000080565458 | ||
996 | ‡2 ISNI|0000000076332109 | ||
996 | ‡2 NKC|ola2006329805 | ||
996 | ‡2 LC|no2014147882 | ||
996 | ‡2 ISNI|0000000495871406 | ||
996 | ‡2 SZ|1251512798 | ||
996 | ‡2 ISNI|0000000036809339 | ||
996 | ‡2 B2Q|0000099476 | ||
996 | ‡2 BIBSYS|90231650 | ||
996 | ‡2 J9U|987007460360905171 | ||
996 | ‡2 LC|no2020025593 | ||
996 | ‡2 ISNI|0000000036678607 | ||
996 | ‡2 CAOONL|ncf11865420 | ||
996 | ‡2 LC|n 93115837 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 | ||
998 | ‡a Brown, Jennifer R. ‡2 J9U|987007350340605171 ‡3 viafid ‡3 title: (0.70, 'chroniclymphocyticleukemia', 'efficacyresultsofaphase2trialof1lineidelalisibplusofatumumabinchroniclymphocyticleukemia') | ||
998 | ‡a Brown, Jennifer R. ‡2 NKC|xx0173543 ‡3 title: (0.70, 'chroniclymphocyticleukemia', 'efficacyresultsofaphase2trialof1lineidelalisibplusofatumumabinchroniclymphocyticleukemia') | ||
998 | ‡a Brown, Jennifer R. ‡2 LC|nb2013010028 ‡3 title: (0.70, 'chroniclymphocyticleukemia', 'efficacyresultsofaphase2trialof1lineidelalisibplusofatumumabinchroniclymphocyticleukemia') |